RAT-HEMATO : Return to Work After Malignant Hemopathy

NANot yet recruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
LeukemiaLymphomaMultiple Myeloma
Interventions
OTHER

"Return-to-work after cancer consultation"

"The return-to-work after cancer consultation is carried out by a specialist in occupational pathology, who may be assisted by a psychologist and/or a nurse and/or a social worker, depending on the patient's personal situation. During this consultation, the team assesses the patient's medical situation, social situation and psychological situation. This consultation lasts approximatively 1 hour and aims to guide the patient in the different stages of return to work, to identify obstacles and apprehensions about return to work, to assess the patient's functional capacities and motivations, to provide information on the legislation, actors and tools for employment maintenance and to discuss possible adjustments of the work situation. The consultation provides a response to potential or encountered problems, directs the patient towards the actors and tools adapted to his/her situation."

Trial Locations (7)

Unknown

Angers University hospital, Angers

Brest University Hospital, Morvan Site, Brest

Caen University hospital, Caen

Rennes University Hospital, Pontchaillou site, Rennes

Centre Henri Becquerel, Rouen

Rouen University Hospital, Rouen

Tours University Hospital, Bretonneau Site, Tours

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT06262789 - RAT-HEMATO : Return to Work After Malignant Hemopathy | Biotech Hunter | Biotech Hunter